Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNN3 encodes a small conductance calcium-activated potassium channel protein (SK3) that regulates neuronal excitability by contributing to the afterhyperpolarization (AHP) following action potentials. It also plays a role in vascular tone regulation and is hormonally regulated in reproductive tissues. Dysregulation of KCNN3 is associated with Zimmermann-Laband Syndrome 3 and has potential links to sleep apnea, SIDS and hypertension.
Channel blocker; Binds calmodulin to regulate calcium binding.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Conductance Calcium-Activated Potassium Channel Subfamily N Member 3 (KCNN3).